Literature DB >> 10462512

trans-sialidase of Trypanosoma cruzi: location of galactose-binding site(s).

M Chuenkova1, M Pereira, G Taylor.   

Abstract

Trypanosoma cruzi expresses a trans-sialidase on its surface, which catalyzes the transfer of sialic acid from mammalian host glycans to its own surface glycoproteins. It has been proposed that the enzyme consists of three domains prior to a long C-terminal repeating sequence that is not required for enzyme activity. The first of these domains shares significant sequence identity with bacterial sialidases which catalyse the hydrolysis of sialic acid. Here we report the sequence of the N-terminal domains of the TS19y trans-sialidase gene, which was expressed in bacteria with the same specific activity as natural enzyme of T. cruzi. Various deletion mutants of TS19y, without the C-terminal tandem repeat, have been cloned and expressed and their trans-sialidase and sialidase activities measured. These experiments show that all three N-terminal domains are required for full trans-sialidase activity, though only the first is necessary for sialidase activity. Some transferase activity is observed, however, even with the shortest construct comprising the first N-terminal domain. Deletion mutants to probe the role of the N-terminal residues of the first domain suggest that the first 33 residues are also required for trans-sialidase activity, but not for sialidase activity. Molecular modelling of the first N-terminal domain of TS19y based on our structures of bacterial sialidases and site-directed mutations suggests the location of a galactose-binding site within this domain. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462512     DOI: 10.1006/bbrc.1999.1154

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Trypanosoma cruzi highjacks TrkC to enter cardiomyocytes and cardiac fibroblasts while exploiting TrkA for cardioprotection against oxidative stress.

Authors:  Daniel Aridgides; Ryan Salvador; Mercio PereiraPerrin
Journal:  Cell Microbiol       Date:  2013-03-14       Impact factor: 3.715

2.  A trypanosomal protein synergizes with the cytokines ciliary neurotrophic factor and leukemia inhibitory factor to prevent apoptosis of neuronal cells.

Authors:  M V Chuenkova; M A Pereira
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

3.  Trypanosoma cruzi trans-sialidase: a potent and specific survival factor for human Schwann cells by means of phosphatidylinositol 3-kinase/Akt signaling.

Authors:  M V Chuenkova; F B Furnari; W K Cavenee; M A Pereira
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

4.  Neurotrophin receptor TrkC is an entry receptor for Trypanosoma cruzi in neural, glial, and epithelial cells.

Authors:  Craig Weinkauf; Ryan Salvador; Mercio Pereiraperrin
Journal:  Infect Immun       Date:  2011-07-25       Impact factor: 3.441

5.  Heterologous expression of Trypanosoma cruzi trans-sialidase in Leishmania major enhances virulence.

Authors:  M Belen Carrillo; W Gao; M Herrera; J Alroy; J B Moore; S M Beverley; M A Pereira
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

6.  Trypanosoma cruzi targets Akt in host cells as an intracellular antiapoptotic strategy.

Authors:  Marina V Chuenkova; Mercio PereiraPerrin
Journal:  Sci Signal       Date:  2009-11-17       Impact factor: 8.192

7.  Chagas' disease parasite-derived neurotrophic factor activates cholinergic gene expression in neuronal PC12 cells.

Authors:  Nsikan Akpan; Kacey Caradonna; Marina V Chuenkova; Mercio PereiraPerrin
Journal:  Brain Res       Date:  2008-04-10       Impact factor: 3.252

8.  Trypanosoma cruzi Neurotrophic Factor Facilitates Cardiac Repair in a Mouse Model of Chronic Chagas Disease.

Authors:  Tamar Ledoux; Daniel Aridgides; Ryan Salvador; Njabulo Ngwenyama; Smaro Panagiotidou; Pilar Alcaide; Robert M Blanton; Mercio A Perrin
Journal:  J Pharmacol Exp Ther       Date:  2018-10-22       Impact factor: 4.030

9.  Trypanosoma cruzi coaxes cardiac fibroblasts into preventing cardiomyocyte death by activating nerve growth factor receptor TrkA.

Authors:  Daniel Aridgides; Ryan Salvador; Mercio PereiraPerrin
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

10.  Trans-sialidase-based vaccine candidate protects against Trypanosoma cruzi infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype.

Authors:  Estefanía Prochetto; Carolina Roldán; Iván A Bontempi; Daiana Bertona; Luz Peverengo; Miguel H Vicco; Luz M Rodeles; Ana R Pérez; Iván S Marcipar; Gabriel Cabrera
Journal:  Oncotarget       Date:  2017-05-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.